Polysaccharides for Colon Targeted Drug Delivery

REFERENCES

• Aberg B.. 1953. Breakdown of dextran by human feces. Scand. J. Clin. Lab. Invest.. 5: 37–38. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Adkin A. D., Kenyon C. J., Lerner E. I., Landau I., Strausss E., Carbon D., Penhasi A., Rubinstein A., Wilding I. R.. 1997. The use of scintigraphy to provide proof of concept for novel polysaccharide preparation designed for colonic drug delivery. Pharm. Res.. 14: 103–107. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ahrabi S. F., Heinamaki J., Sande S. A., Graffner C.. 2000a. Development of pectin matrix tablets for colonic delivery of model ropivacaine. Eur. J. Pharm. Sci.. 10: 43–52. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ahrabi S. F., Heinamaki J., Sande S. A., Graffner C.. 2000b. Influence of neutron activation factors on matrix tablets for site specific delivery to the colon. Eur. J. Pharm. Sci.. 10: 225–235. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Aiedeh K., Taha M. O.. 1999. Synthesis of chitosan succinate and chitosan phthalate and their evaluation as suggested matrices in orally administered colon-specific drug delivery systems. Arch. Pharm. (Weinheim.). 332: 103–107. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Akbuga J., Durmaz D.. 1994. Preparation and evaluation of crosslinked chitosan microspheres containing furosemide. Int. J. Pharm.. 11: 217–222. [CROSSREF]
   Web of Science ®Google Scholar
• Andersen G. H., Robbins F. M., Domingues F. J., Morres R. G., Long C. L.. 1983. The utilisation of schardinger dextrins by the rat. Toxicol. Appl. Pharmacol.. 5: 257–266. [CROSSREF]
   Web of Science ®Google Scholar
• Antenucci R., Palmer J. K.. 1984. Enzymatic degradation of α and β-cyclodextrins by bacteroids of the human colon. J. Agric. Food Chem.. 32: 1316–1321
   Web of Science ®Google Scholar
• Ashford M., Fell J. T., Attwood D., Sharma H., Woodhead P.. 1993. An evaluation of pectin as a carrier for drug targeting to colon. J. Control. Rel.. 26: 213–220. [CROSSREF]
   Web of Science ®Google Scholar
• Ashford M., Fell J. T., Attwood D., Sharma H., Woodhead P.. 1994. Studies on pectin formulations for colonic drug delivery. J. Control. Rel.. 30: 225–232. [CROSSREF]
   Web of Science ®Google Scholar
• Azad Khan A. K., Truelove S. C., Aronseq J. K.. 1982. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br. J. Clin. Pharmacol.. 13: 523–528
   PubMed Web of Science ®Google Scholar
• Bauer K. H., Kesselhut J. F.. 1995. Novel pharmaceutical excipients for colon targeting. STP Pharm. Sci.. 5: 54–59
   Google Scholar
• Bayliss C. E., Houston A. P.. 1986. Degradation of guar gum by faecal bacteria. Appl. Environ. Microbiol.. 48: 626–632
   Google Scholar
• Berthold A., Cremer K., Kreuter J.. 1996. Influence of crosslinking on the acid stability and physicochemical properties of chitosan microspheres. STP Pharm. Sci.. 6: 358–364
   Google Scholar
• Brondsted H., Andersen C., Hovgaard L.. 1998. Crosslinked dextran—a new capsule material for colon targeting of drugs. J. Control. Rel.. 53(1–3)7–13. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brondsted H., Hovgaard L., Simonsen J.. 1995a. Dextran hydrogels for colon-specific drug delivery. III., In vitro and in vivo degradation. STP Pharm. Sci.. 5: 60–64
   Google Scholar
• Brondsted H., Hovgaard L., Simonsen J.. 1995b. Dextran hydrogels for colon-specific drug delivery. IV. Comparative release mechanism of hydrocortisone and prednisolone phosphate. STP Pharm. Sci.. 5: 65–69
   Google Scholar
• Chan R. P., Pope D. J., Gilbert A. P., Baron J. H., Lennard-Jones J. P.. 1983. Studies of two novel sulfaslazine analogue: ipsalazine and balsalazine. Dig. Dis. Sci.. 28: 609–615. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chickering D. E., Mathiowitz E.. 1995. Bioadhesive microspheres. I. A novel electrobalance-based method to study adhesive interactions between individual microspheres and intestinal mucosa. J. Control. Rel.. 34: 251–262. [CROSSREF]
   Web of Science ®Google Scholar
• Chickering D. E., Jacob J. S., Mathiowitz E.. 1995. Bioadhesive microspheres. 2. Characterisation and evaluation of bioadhesion involving hard, bioerodible polymers and soft-tissue. Reacting Polymers. 25: 189–206. [CROSSREF]
   Web of Science ®Google Scholar
• Chiu H. C., Hsiue G. H., Lee Y. P., Huang L. W.. 1999. Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system. J. Biomater. Sci. Polym. Ed.. 10: 591–608. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Coates J. H., Easton C. J., Fryer N. L., Lincolin S. F.. 1994. Complementary diastereo selectivity in the synthesis and hydrolysis of acylated cyclodextrins. Chem. Lett.. 1153–1156
   Web of Science ®Google Scholar
• Cui N., Friend D. R., Fedorak R. N.. 1994. A budesonide prodrug accelerates treatment of colitis in rats. Gut. 35: 1439–1446. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cummings J. H., Englyst H. N.. 1987. Fermentation in the human large intestine and available substrates. Am. J. Clin. Nutr.. 45: 1243–1247. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cummings J. H., Southgate D. A. T., Branch W. J., Wiggins H. S., Houston H., Jenkins D. J. A., Jirraj T., Hill M. J.. 1979. The digestion of pectin in human gut and its effect on calcium absorption and large bowel function. Br. J. Nutr.. 41: 477–485. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cummings J. H., Milojevic S., Harding M., Coward W. A., Gibson G. R., Botham R. L., Ring S. G., Wraight E. P., Stockham M. A., Allwood M. C., Newton J. M.. 1996. In vivo studies of amylose- and ethylcellulose-coated [13C]glucose microspheres as a model for drug delivery to the colon. J. Control. Rel.. 40: 123–131. [CROSSREF]
   Web of Science ®Google Scholar
• Dysseler B. S., Hoffen M. J.. 1995. Inulin, an alternative dietary fiber. Properties and quantitative analysis. Eur. J. Clin. Nutr.. 49: S145–S152. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• El-Gibaly I.. 2002. Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int. J. Pharm.. 232: 199–211. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Englyst H. N.. 1987. Digestion of the polysaccharides of potato in the small intestine of man. Am. J. Clin. Nutr.. 45: 423–431. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Englyst H. N., Cummings J. H.. 1985. Digestion of the polysaccharides of some cereal foods in the human small intestine. Am. J. Clin. Nutr.. 42: 778–787. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Englyst H. N., Cummings J. H.. 1986. Digestion of the polysaccharides of banana (Musa paradisinca sapietum) in man. Am. J. Clin. Nutr.. 44: 42–50. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Englyst H. N., Wiggins H. S., Cummings J. H.. 1982. Determination of nonstarch polysaccharides in plant foods by gas liquid chromatography of constituent sugars as alditol acetates. Analyst. 107: 307–318. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Englyst H. N., Hay S., MacFarlane G. T.. 1987. Polysaccharide breakdown by mixed populations of human faecal bacteria. FEMS Microbiol. Ecol.. 95: 163–171
   Web of Science ®Google Scholar
• Englyst H. N., Kingman S. M., Cummings J. H.. 1992. Classification and measurement of nutritionally important starch fractions. Eur. J. Clin. Nutr.. 46: S33–S50. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fernandez-Hervas M. J., Fell J. T.. 1998. Pectin/chitosan mixtures as coatings for colon-specific drug delivery: An in vitro evaluation. Int. J. Pharm.. 169: 115–119. [CROSSREF]
   Web of Science ®Google Scholar
• Flourie B., Molis C., Achour L., Dupas H., Hatat C., Rambaud J. C.. 1993. Fate of β-cyclodextrin in the human intestine. J. Nutr.. 123: 676–680. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Friend D. R.. 1992. Glycosides in colonic drug delivery. Oral Colon Specific Drug Delivery, D. R., Friend, 153–187, Boca Raton, FL, CRC Press
   Google Scholar
• Friend D. R., Chang G. W.. 1984. A colon-specific drug delivery based on the drug glycosidases of colonic bacteria. J. Med. Chem.. 27: 261–266. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Friend D. R., Phillips S., McLeod A., Tozer T. N.. 1991. Relative anti-inflammatory effect of oral dexamethasone-β-D-glucoside and dexamethasone in experimental IBD. Proc. Int. Control. Bioact. Mater.. 18: 612–613
   Google Scholar
• Fukui E., Miyamura M., Kobayashi M.. 2001. An in vitro investigation of the suitability of press-coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting. J. Control. Rel.. 70: 97–107. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Furda I.. 1983. Aminopolysaccharides—their potential as dietary fiber. Unconventional Sources of Dietary Fiber, Physiological and In Vitro Functional Properties, I., Furda, 105–122, Washington, DC, American Chemical Society
   Google Scholar
• Gazzaniga A., Bussetti C., Moro L., Sangali M. E., Giordano F.. 1995. Time dependent oral delivery system for colon targeting. STP Pharm. Sci.. 5: 83–88
   Google Scholar
• Gazzaniga A., Iamartino P., Maffione G., Sangalli M. E.. 1994. Oral delayed release system for colon specific drug delivery. Int. J. Pharm.. 108: 77–83. [CROSSREF]
   Web of Science ®Google Scholar
• Gerloczy A., Fonagy A., Keresztes P., Perlaky L., Szejtli J.. 1985. Absorption, distribution, excretion and metabolism of orally administered 14C-β-cyclodextrin in rat. Arzneim Forsch/Drug Res.. 35: 1042–1047
   PubMed Web of Science ®Google Scholar
• Gibson G. R., Roberfroid M. R.. 1995. Dietary modulation of the human colonic microflora: introducing the concept of prebiotics. J. Nutr.. 125: 1401–1414. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gilko-Kabir I., Yagen B., Penhasi A., Rubinstein A.. 1998. Low swelling crosslinked guar and its potential use as colon-specific drug carrier. Pharm. Res.. 15: 1019–1025. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gilko-Kabir I., Yagen B., Penhasi A., Rubinstein A.. 2000a. Phosphated crosslinked guar for colon-specific drug delivery. I. Preparation and physicochemical characterization. J. Control. Rel.. 63: 121–127. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gilko-Kabir I., Yagen B., Baluom M., Rubinstein A.. 2000b. Phosphated crosslinked guar for colon-specific drug delivery. II In vitro and in vivo evaluation. J. Control. Rel.. 63: 129–134. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Goldsten A. M., Alter E. N., Seaman J. K.. 1992. Guar gum. Oral Colon-Specific Drug Delivery and Their Derivatives, R. L., Whistler, 1–43, , NY, Plenum Press
   Google Scholar
• Gupta V. K., Beckert T. E., Price J. C.. 2001a. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int. J. Pharm.. 213: 83–91. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gupta V. K., Assmus M. W., Beckert T. E., Price J. C.. 2001b. A novel pH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables. Int. J. Pharm.. 213: 93–102. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Harboe E., Larsen C., Johansen M., Olesen H. P.. 1989a. Macromoleculer prodrugs. XIV. Absorption characteristics of naproxen after oral administration of a dextran T-70-naproxen ester prodrugs in pigs. Int. J. Pharm.. 53: 157–165. [CROSSREF]
   Web of Science ®Google Scholar
• Harboe E., Larsen C., Johansen M., Olesen H. P.. 1989b. Macromoleculer prodrugs. XV. Colon targeted delivery. bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig. Pharm. Res.. 6: 919–923. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Harboe E., Johansen M., Larsen C.. 1988. Macromolecular prodrugs. VI. Coupling of the highly lipophilic agent naproxen to dextrans and in vitro characterization of the conjugates. Farmaci. Sci. Ed.. 16: 73–85
   Google Scholar
• Hardy J. G., Evans D. F., Zaki I., Clark A. G., Tonnesen H. H., Gamst O. N.. 1987. Evaluation of an enteric coated naproxen tablet using gamma scintigraphy and pH monitoring. Int. J. Pharm.. 37: 245–250
   Web of Science ®Google Scholar
• Hehre E. J., Sery T. W.. 1952. Dextran splitting anaerobic bacteria from the human intestine. J. Bacteriol.. 63: 424–426
   PubMed Web of Science ®Google Scholar
• Hergenrother R. W., Wabers H. D., Cooper S. L.. 1992. The effect of chain extenders and stabilizers on the in vivo stability of polyurethanes. J. Appl. Biomat.. 3: 17–22
   Google Scholar
• Hiramaya F., Minami K., Uekama K.. 1996. In vitro evaluation of biphenyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media. J. Pharm. Pharmacol.. 48: 27–31
   PubMed Web of Science ®Google Scholar
• Hirsch S., Binder V., Kolter K., Kesselhut J. F., Bauer K. H.. 1997. Lauroyldextran as a coating material for site-specific drug delivery to the colon: in-vitro dissolution of coated-tablets. Proc. Int. Symp. Control. Rel. Bioact. Mater.. 24: 379–380
   Google Scholar
• Hirsch S., Binder V., Kolter K., Kesselhut J. F., Bauer K. H.. 1999. Lauroyldextran and cross-linked galactomannan as coating materials for site-specific drug delivery to the colon. Eur. J. Pharm. Biopharm.. 47: 61–71. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hovgaard L., Brondsted H.. 1995. Dextran hydrogels for colon-specific drug delivery. J. Control. Rel.. 36: 159–166. [CROSSREF]
   Web of Science ®Google Scholar
• Huang S. L., Bansleben D. A., Knox J. R.. 1979. Biodegradable polymers: chymotrypsin degradation of low molecular weight poly(ester-urea) containing phenylalaline. J. Appl. Polym. Sci.. 23: 429–437. [CROSSREF]
   Web of Science ®Google Scholar
• Jain, Nitin K., Chourasia M. K., Jain S., Jain S. K., Jain N. K.. 2003. Development and characterization of engineered commensal bacteria for the delivery of enzymes. Ind. J. Pharm. Sci.. 65: 113–121
   Google Scholar
• Johansen M., Larsen C.. 1984. Stability kinetics and hydrolysis of metronidazole monosuccinate in aqueous solution and in plasma. Int. J. Pharm.. 21: 201–209. [CROSSREF]
   Google Scholar
• Johansen M., Larsen C.. 1985. A comparison of the chemical stability and the enzymatic hydrolysis of a series of aliphatic and aromatic ester derivatives of metronidazole. Int. J. Pharm.. 27: 219–231. [CROSSREF]
   Google Scholar
• Johnson J. C., Gee J. M.. 1981. Effect of gel forming gum on the intestinal unstirred layer and sugar transport in vitro. Gut. 22: 398–403. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jung Y. J., Lee J. S., Kim H. H., Kim Y. K., Kim Y. M.. 1998. Synthesis and properties of dextran-5-amino salicylic acid ester as a potential colon-specific prodrug of 5-amino salicylic acid. Arch. Pharm. Res.. 21: 179–186. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Karunaratne D. N., Farmer S., Hancock R. E. W.. 1993. Synthesis of bulky beta-lactams for inhibition of cell surface beta-lactamase activity. Bioconjug. Chem.. 4: 434–439. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kenyon C. J., Nardi R. V., Wong D., Hooper G., Wilding I. R., Friend D. R.. 1997. Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation. Aliment. Pharmacol. Ther.. 11: 205–213. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Khan M. Z., Prebeg Z., Kurjakovic N.. 1999. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers I. Manipulation of drug release using Eudragit® L100–55 and Eudragit® S100 combinations. J. Control. Rel.. 58: 215–222. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kiyoung L., Kun N., Yueim K.. 1999. Polysaccharides as a drug coating polymer. Polym. Prep.. 40: 359–360
   Google Scholar
• Krishnaiah Y. S. R., Satyanarayana S., Rama Prasad Y. V., Narasimha Rao S.. 1998. Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy subjects. J. Control. Rel.. 55: 245–252. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Krishnaiah Y. S. R., Satyanarayana S., Rama Prasad Y. V.. 1999. Studies of guar gum compression coated 5-aminosalicylic acid tablets for colon-specific delivery. Drug Dev. Ind. Pharm.. 25: 651–657. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Krishnaiah Y. S. R., Veer Raju P., Dinesh Kumar B., Bhaskar P., Satyanarayana V.. 2001. Development of colon targeted drug delivery systems for mebendazole. J. Control. Rel.. 77: 87–95. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Krishnaiah Y. S. R., Satyanarayana V., Dinesh Kumar B., Karthikeyan R. S.. 2002a. Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer. J. Drug Target.. 10: 247–254. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Krishnaiah Y. S., Satyanarayana V., Dinesh Kumar B., Karthikeyan R. S.. 2002b. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur. J. Pharm. Sci.. 16: 185–92. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Larsen C., Johansen M.. 1989. Macromolecular prodrugs XI. Regeneration rates of various NSAID compounds from their corresponding dextran ester prodrugs in aqueous buffer and in different biological media. Acta Pharm. Nord.. 2: 57–66
   Google Scholar
• Larsen C., Jensen B. H., Olesen H. P.. 1991a. Stability of ketoprofen-dextran ester prodrugs in homogenates of various segments of the pig GI tract. Acta Pharm. Nord.. 3: 41–44. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Larsen C., Jensen B. H., Johansen M., Olesen H. P.. 1991b. Bioavailability of ketoprofen from orally administered ketoprofen dextran ester prodrug in the pig. Acta. Pharm. Nord.. 3: 71–76. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Larsen C., Harboe E., Johansen M., Olesen H. P.. 1989a. Macromolecular prodrugs. XVI. Colon targeted delivery. Comparison of the rate of release of naproxen from dextran ester prodrug in homogenates of various segments of the pig gastrointestinal tract. Pharm. Res.. 6: 995–999. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Larsen C., Harboe E., Johansen M., Olesen H. P.. 1989b. Macromoleculer prodrugs. XV. Colon targeted delivery. Bioavailability of naproxen from orally administered dextran ester prodrugs varying molecular size in the pig. Pharm. Res.. 6: 919–923. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lee J. S., Jung Y. J., Doh M. J., Kim Y. M.. 2001. Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid. Drug Dev. Ind. Pharm.. 27: 331–336. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lenaerts V., Dumoulin Y., Mateescu M. A.. 1991. Controlled release of theophylline from crosslinked amylose tablets. J. Control. Rel.. 15: 39–46. [CROSSREF]
   Web of Science ®Google Scholar
• Levitt M. D., Hirsh P., Fetzer C. A., Sherman M., Levine A. S.. 1987. H2 excretion after ingestion of complex carbohydrates. Gastroenterology. 92: 383–386. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lorenzo-Lamosa M. L., Remunan-Lopez C., Vila-Jato J. L., Alonso M. J.. 1998. Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Rel.. 52: 109–118. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Macfarlane G. T., Hay S., Macfarlane S., Gibson G. R.. 1990. Effect of different carbohydrates on growth polysaccharidases and glycosidase production of Bacteroides ovatus in batch and continuous culture. J. Appl. Bacteriol.. 68: 179–187. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Macleod G. S., Fell J. T., Collett J. H.. 1997. Studies on the physical properties of mixed pectin/ethylcellulose films intended for colonic drug delivery. Int. J. Pharm.. 157: 53–60. [CROSSREF]
   Web of Science ®Google Scholar
• Macleod G. S., Fell J. T., Collett J. H., Sharma J. L., Smith A. M.. 1999. Selective drug delivery to the colon using pectin: chitosan: hydroxypropyl methylcellulose film coated tablets. Int. J. Pharm.. 187: 251–257. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• MacNeil M. E., Rashid A., Stevens H. N. F.. 1990. Dispensing device. World Patent, WO 9009168
   Google Scholar
• Maris B., Verheyden L., Reeth K. V., Samyn C., Augustijns P., Kinget R., Van den Mooter G.. 2001. Synthesis and characterisation of inulin-azo hydrogels designed for colon targeting. Int J. Pharm.. 213: 143–152. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Markus, Rudolph W., Klein S., Beckert T. E., Petereit H., Dressman J. B.. 2001. A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. Eur. J. Pharm. Biopharm.. 51: 183–190. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McKeller R. C., Modler H. W.. 1989. Metabolism of fructooligosaccharides by Biffidobacterium spp. Appl. Microbiol. Biotechnol.. 31: 537–541. [CROSSREF]
   Web of Science ®Google Scholar
• McLeod A. D., Friend D. R., Tozer T. N.. 1993. Synthesis and chemical stability of glucocorticoid-dextran ester: potential prodrugs for colon-specific drug delivery. Int. J. Pharm.. 92: 105–114. [CROSSREF]
   Web of Science ®Google Scholar
• McLeod A. D., Fedorak R. N., Friend D. R., Tozer T. N., Cui N.. 1994a. A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression. Gastroenterology. 106: 405–413. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McLeod A. D., Tolentino L., Tozer T. N.. 1994b. Glucocorticoid-dextran ester conjugates as potential prodrugs for colon-specific drug delivery: steady-state pharmacokinetics in rat. Biopharm. Drug Dispos.. 15: 151–164. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Meshali M. M., Gabar K. E.. 1993. Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behaviour of chlorpromazine HCI. Int. J. Pharm.. 89: 177–181. [CROSSREF]
   Web of Science ®Google Scholar
• Milojevic S., Newton J. M., Cummings J. H., Gibson G. R., Botham R. L., Ring S. C., Stockham M., Allwood M. C.. 1996a. Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J. Control. Rel.. 38: 75–84. [CROSSREF]
   Web of Science ®Google Scholar
• Milojevic S., Newton J. M., Cummings J. H., Gibson G. R., Botham R. L., Ring S. C., Stockham M., Allwood M. C.. 1996b. Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using glucose pellets. J. Control. Rel.. 38: 85–94. [CROSSREF]
   Web of Science ®Google Scholar
• Minami K., Hiramaya F., Uekama K.. 1998. Colon-specific drug delivery based on a cyclodextrin prodrug: release behaviour of biphenyl acetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration. J. Pharm. Sci.. 87: 715–720. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moore W. E. C., Holdeman L. V.. 1975. Discussion of current bacteriological investigations of the relationship between intestinal flora, diet and colon cancer. Cancer Res.. 35: 3418–3420
   Web of Science ®Google Scholar
• Morishita I., Morishita M., Takayama K., Machida Y., Nagai T.. 1993. Enteral insulin delivery by microspheres in three different formulations using Eudragit L100 and S100. Int. J. Pharm.. 91: 29–37. [CROSSREF]
   Web of Science ®Google Scholar
• Munjeri O., Collett J. H., Fell J. T.. 1997. Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug release. J. Control. Rel.. 46: 273–278. [CROSSREF]
   Web of Science ®Google Scholar
• Muraoka M., Hu Z., Shimokawa T., Sekino S., Kurogoshi R., Kuboi Y., Yoshikawa Y., Takada K.. 1998. Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. J. Control. Rel.. 52: 119–129. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Omrod D. J., Holmes C. C., Miller T. E.. 1998. Dietary chitosan inhibits hypercholesterolaemia and antherogensis in the apoliprotein E-deficient mouse model of atherosclerosis. Atherosclerosis. 138: 329–334. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Orienti I., Cerchiara T., Luppi B., Bigucci F., Zuccari G., Zecchi V.. 2002. Influence of different chitosan salt on the release of sodium diclofenac in colon-specific delivery. Int. J. Pharm.. 238: 51–59. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Park K., Shalaby S. W. W., Park H.. 1993. Biodegradation. Biodegradable Hydrogels for Drug Delivery, J., Guillet, 13–34, Lancaster, PA, Technomic Publishing
   Google Scholar
• Potts J. E., Clendianaings R. A., Ackard B.. 1973. The Biodegradability of Synthetic Polymers. Polymer Science and Technology. vol. 3. ed., J., Guillet, 61–79, New York, Plenum Press
   Google Scholar
• Raghavan C. V., Muthulingam C., Leno Jenita J. A. J., Ravi T. K.. 2002. An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting. Int. J. Pharm.. 50: 892–895
   Google Scholar
• Rama Prasad Y. V., Krishnaiah Y. S. R., Satyanarayana S.. 1998. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J. Control. Rel.. 51: 281–287
   PubMed Web of Science ®Google Scholar
• Ratner B. D., Gladhill K. W., Hobert T. A.. 1988. Analysis of in vitro enzymatic and oxidative degradation polyurethanes. J. Biomed. Mater. Res.. 22: 509–527. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rihova B.. 1995. Bioadhesive polymers for oral drug delivery. Adv. Exp. Med. Biol.. 371B: 1491–1494. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Rodriguez M., Antunez J. A., Taboada C., Seijo B., Torres D.. 2001. Colon-specific delivery of budesonide from microencapsulated cellulosic cores: evaluation of the efficacy against colonic inflammation in rats. J. Pharm. Pharmacol.. 53: 1207–1215. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rodriguez M., Vila-Jato J. L., Torres D.. 1998. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J. Control. Rel.. 55: 67–77. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rubinstein A.. 1990. Microbially controlled drug delivery to the colon. Biopharm Drug Dispos.. 11: 465–475. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Radai R.. 1991. Pectic salt as a colonic drug delivery system. Proc. Int. Symp. Control. Rel. Bioact. Mater.. 18: 221–222
   Google Scholar
• Rubinstein A., Radai R.. 1995. In vitro and in vivo analysis of colon specifically of calcium pectinate formulations. Eur. J. Pharm. Biopharm.. 41: 291–295
   Web of Science ®Google Scholar
• Rubinstein A., Gilko-Kabir I.. 1995. Synthesis and swelling-dependent enzymatic degradation of borax-modified guar gum for colonic delivery purposes. STP Pharm. Sci.. 51: 41–46
   Google Scholar
• Rubinstein A., Nakar D., Sintov A.. 1992a. Colonic drug delivery: enhanced release of indomethacin from cross linked chondroitin matrix in rat caecal content. Pharm. Res.. 9: 276–278. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Nakar D., Sintov A.. 1992b. Chondroitin sulphate: a potential prodrug for colon-specific drug delivery. Int. J. Pharm.. 84: 141–150. [CROSSREF]
   Web of Science ®Google Scholar
• Rubinstein A., Radai R., Ezra M., Pathak S., Rokem J. M.. 1993. In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier. Pharm. Res.. 10: 258–263. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Pathak S., Friendman M., Rokem J. S. R.. 1990. In vitro method for drug release analysis for microbially controlled drug delivery. Proc. Int. Symp. Control. Rel. Bioact. Mater.. 17: 466–467
   Google Scholar
• Saffran M., Bedra C., Kumar G. S., Neckers D. C.. 1988. Vasopressin: A new model for the study of effects of additives on the oral and rectal administration of peptide drugs. J. Pharm. Sci.. 77: 33–38. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Saffran M., Kumar G. S., Savariar C., Burnham J. C., Williams F., Neckers D. C.. 1986. A new approach to the oral administration of insulin and other peptide drugs. Science. 233: 1081–1084. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Salyers A. A.. 1979. Energy sources of major intestinal fermentative anaerobes. Am. J. Clin. Nutr.. 32: 158–163. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Salyers A. A., O'Brien M.. 1980. Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron. J. Bacteriol.. 143: 772–780. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schacht E., Gevaert A., Kenawy E. R.. 1996. Polymers for colon specific drug delivery. J. Control. Rel.. 39: 327–328. [CROSSREF]
   Web of Science ®Google Scholar
• Schacht E., Callant D., Verstraete W.. 1991. Synthesis and evaluation of polymeric prodrugs of 5-aminosalicylic acid. Proc. Int. Symp. Contr. Rel. Bioact. Mater.. 18: 686–687
   Google Scholar
• Scheline R. R.. 1973. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol. Res.. 25: 451–523
   Google Scholar
• Semde R., Amighi K., Moes A. J.. 1998. Epichlorhydrin cross-linked pectins for colonic drug delivery. Proc. Int. Symp. Control. Rel. Bioact. Mater.. 25: 806–807
   Google Scholar
• Semde R., Amighi K., Devleeschouwer M. J., Moes A. J.. 2000a. Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate. Int. J. Pharm.. 197: 169–179. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Semde R., Amighi K., Devleeschouwer M. J., Moes A. J.. 2000b. Studies of pectin HM/Eudragit RL/Eudragit NE film-coating formulations intended for colonic drug delivery. Int. J. Pharm.. 197: 181–192. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shibata N., Ohno T., Shimokawa T., Hu Z., Yoshikawa Y., Koga K., Murakami M., Takada K.. 2001. Application of pressure-controlled colon delivery capsules to oral administration of glycyrrizin in dogs. J. Pharm. Pharmacol.. 53: 441–447. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shimono N., Takatori T., Masumi T., Ueda M., Mori M., Higashi Y., Nakamura Y.. 2002. Chitosan dispersed system for colon-specific drug delivery. Int. J. Pharm.. 245: 45–54. [CROSSREF], [PUBMED], [INFOTRIEVE]
   Google Scholar
• Shu X. Z., Zhu K. J., Song W.. 2001. Novel pH-sensitive citrate crosslinked chitosan film for drug controlled release. Int. J. Pharm.. 212: 19–28. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shun Y. L., Ayres J. W.. 1992. Calcium alginate beads as core carriers of 5-aminosalicylic acid. Pharm. Res.. 9: 714–790
   Web of Science ®Google Scholar
• Siew L. F., Basit A. W., Netwon J. M.. 2000. The properties of amylose-ethyl cellulose films cast from organic based solvents as potential coating colonic drug delivery. Eur. J. Pharm. Sci.. 11: 133–139. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Simonsen L., Hovgaard L., Mortensen P. B., Bronsted H.. 1995. Dextran hydrogels for colon-specific drug delivery. V. Degradation in human intestinal incubation models. Eur. J. Pharm. Sci.. 3: 329–337. [CROSSREF]
   Web of Science ®Google Scholar
• Sintov A., Di-Capua N., Rubinstein A.. 1995. Cross-linked chondroitin sulphate: characterization for drug delivery purposes. Biomaterials. 16: 473–478. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Spitael J., Kinget R.. 1977. Factors affecting the dissolution rate of enteric coatings. Pharm. Ind.. 39: 502–505
   Google Scholar
• Spitael J., Kinget R.. 1979. Solubility and dissolution rate of enteric polymers. Acta Pharm. Technol.. 25: 163–168
   Google Scholar
• Spitael J., Kinget R.. 1980. Influence of solvent composition upon film-coating. Pharm. Acta Helv.. 55: 157–160. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Spitael J., Kinget R., Naessens K.. 1980. Dissolution rate of cellulose acetate phthalate and Bronsted catalysis. Pharm. Ind.. 42: 846–849
   Google Scholar
• Sriamornsak P., Nunthanid J.. 1998. Calcium pectinate gel beads for controlled release drug delivery: I. Preparation and in vitro release studies. Int. J. Pharm.. 160: 207–212. [CROSSREF]
   Web of Science ®Google Scholar
• Steggerda F. R.. 1968. Gastroinestinal gas following food consumption. Ann. N.Y. Acad Sci.. 150: 57–61. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stella V. J., Rajewski R. A.. 1997. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res.. 14: 556–567. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stubbe B., Maris B., Van den Mooter G., Demeester J.. 2001. The in vitro evaluation of azo containing polysaccharide gels' for colon delivery. J. Control. Rel.. 75: 103–114. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Suzuki T., Matsumoto T., Hagino Y., Tozaki H., Yamamoto A., Muranishi S.. 1998. Biodegradation and medical applications of chitosan hard capsules. Sci. Technol. Polym. Adv. Mater., Prasad P., 567–571., 4th ed., New York, Plenum Press
   Google Scholar
• Swanson D., Barclay B., Wong P., Theeuwes F.. 1987. Nifedipine gastro-intestinal, therapeutics system. Am. J. Med.. 83: 3–5. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Swift G.. 1992. Biodegradable polymers in the environment: are they really biodegradable?. Proc. ACS Div. Polym. Mat. Sci. Eng.. 66: 403–404
   Google Scholar
• Takaya T., Niwa K., Muraoka M., Ogita I., Nagai N., Yano R., Kimura G., Yoshikawa Y., Yoshikawa H., Takada K.. 1998. Importance of dissolution process on systemic availability of drugs delivered by colon delivery system. J. Control. Rel.. 50: 111–122. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tanaka H., Kominato K., Yamamoto R.. 1994. Synthesis of doxorubicin-cyclodextrin conjugates. J. Antibiot.. 47: 1025–1029. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Thanoo B. C., Sunny M. C., Jaykrishnan A.. 1992. Crosslinked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol.. 44: 283–286. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Theeuwes F., Guittard G., Wong P.. 1990. Delivery of drugs to colon by oral dosage forms. U.S. Patent 4904474
   Google Scholar
• Thimma R. T., Tammishetti S.. 2001. Barium chloride crosslinked carboxymethyl guar gum beads for gastrointestinal drug delivery. J. Appl. Poly. Sci.. 82: 3084–3090. [CROSSREF]
   Web of Science ®Google Scholar
• Toledo O. M. S., Dietrich C. P.. 1977. Tissue specific distributions of sulfated mucopolysaccharides in mammals. Biochim. Biophys. Acta. 498: 114–122. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tomlin B. J., Read N. W., Edwards C. A., Duerden B. J.. 1986. The degradation of guar gum by fecal incubation system. Brit. J. Nutr.. 55: 481–486. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tomolin J., Taylor J. S., Read N. W.. 1989. The effect of mixed faecal bacteria on a selection of viscous polysaccharide in vitro. Nutr. Rep. Int.. 39: 121–135
   Google Scholar
• Touitou E., Rubinstein A.. 1986. Targeted eternal delivery of insulin to rats. Int. J. Pharm.. 30: 95–99. [CROSSREF]
   Web of Science ®Google Scholar
• Towle G. A., Christensen O.. 1973. Pectin. Industrial Gums and Their Derivatives, R. L., Whistler, J. N., BeMiller, 429–461, New York, Academic Press
   Google Scholar
• Tozaki M., Emi Y., Horisaka E., Fujita T., Yamamoto A., Muranishi S.. 1997a. Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: implications in peptide delivery to the colon. J. Pharm. Pharmacol.. 49: 164–168. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tozaki H., Komoike J., Tada C., Maruyama T., Terabe A., Suzuki T., Yamamoto A., Muranishi S.. 1997b. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharm. Sci.. 86: 1016–1021. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tozaki M., Fujita T., Odoriba T.. 1999. Colon specific delivery of R68070, a new thromboxane synthetase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sci.. 64: 1155–1162. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tozaki H., Odoriba T., Okada N., Fujita T., Terabe A., Suzuki T., Okabe S., Murnishi S., Yamamoto A.. 2002. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J. Control. Rel.. 82: 51–61
   PubMed Web of Science ®Google Scholar
• Tozer T. N., Rigod J., McLeod A. D., Gungon R., Hong M. K., Friend D. R.. 1991. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig. Pharm. Res.. 8: 445–454. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Turkoglu M., Ugurlu T.. 2002. In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur. J. Pharm. Biopharm.. 53: 65–73. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Uekama K., Hiramaya F., Irie T.. 1991. Pharmaceutical uses of cyclodextrin derivatives. High Performance Biomaterials, M., Szycher, 789–786, Lancaster, PA, Technomic Publishing
   Google Scholar
• Uekama K., Minami K., Hirayama F.. 1997. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta- and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery. J. Med. Chem.. 40: 2755–2761. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Van den Mooter G., Samyn C., Kinget R.. 1992. Azo polymers for colon-specific drug delivery. Int. J. Pharm.. 87: 37–46. [CROSSREF]
   Web of Science ®Google Scholar
• Van den Mooter G., Samyn C., Kinget R.. 1993. Azo polymers for colon-specific drug delivery. Part II: influence of the type of azo polymer on the degradation by intestinal microflora. Int. J. Pharm.. 97: 133–139. [CROSSREF]
   Web of Science ®Google Scholar
• Vandelli M. A., Leo E., Forni F., Bernatei M. T.. 1996. In vitro evaluation of a potential colonic drug delivery system that releases drug after a controllable lag-time. Eur. J. Pharm. Biopharm.. 43: 148–151
   Google Scholar
• Van Soest P. J.. 1978. Dietary fibers: their definition and nutritional properties. Am. J. Clin. Nut.. 31: S12
   PubMed Web of Science ®Google Scholar
• Vermeersch J., Vandoorne F., Permentier D., Schacht E.. 1985. Macromoleculer prodrugs of metronidazole I. Esterification of hydroxyl containing polymers with metronidazole monosuccinate. Bull. Soc. Chim. Belg.. 94: 591–596
   Google Scholar
• Vervoort L., Kinget R.. 1996. In vitro degradation by colonic bacteria of inulin HP incorporated in Eudragit films. Int J. Pharm.. 129: 185–190. [CROSSREF]
   Web of Science ®Google Scholar
• Vervoort L., Van den Mooter G., Augustijns P., Busson R., Toppet S., Kinget R.. 1997. Inulin hydrogels as carrier for colonic drug targeting. I. Synthesis and characterization of methacrylated inulin and hydrogel formation. Pharm. Res.. 14: 1730–1736. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Vervoort L., Rombaut P., Van den Mooter G., Augustijns P., Kinget R.. 1998a. Inulin hydrogels. I. Dynamic and equilibrium swelling properties. Int. J. Pharm.. 172: 127–135. [CROSSREF]
   Web of Science ®Google Scholar
• Vervoort L., Rombaut P., Van den Mooter G., Augustijns P., Kinget R.. 1998b. Inulin hydrogels. II. In vitro degradation study. Int. J. Pharm.. 172: 137–145. [CROSSREF]
   Web of Science ®Google Scholar
• Wakerly Z., Fell J. T., Attwood D., Parkins D.. 1996. Pectin/ethyl cellulose film coating formulations for colonic drug delivery. Pharm. Res.. 13: 1210–1212. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wakerly Z., Fell J. T., Attwood D., Parkins D.. 1997. Studies on drug release from pectin/ethylcellulose film-coated tablets: a potential colonic delivery system. Int. J. Pharm.. 153: 219–224. [CROSSREF]
   Web of Science ®Google Scholar
• Wang X., Gibson G. R.. 1993. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J. Appl. Bacterol.. 75: 373–380
   PubMedGoogle Scholar
• Wastenson A.. 1971. Properties of fractionated chondroitin sulfate form ox nasal septa. Biochem. J.. 122: 477–785
   PubMed Web of Science ®Google Scholar
• Weiner M. L.. 1993. An overview of the regulatory status and of the safety of chitin and chitosan as food and pharmaceutical ingredients. Advances in Chitin and Chitosan., Brine C. J., P. A., Sandford, J. P., Zikakis, 663–672, London, Elsevier Applied Sciences
   Google Scholar
• Willoughby C. P., Aronson J. K., Agback H., Bodin N. O., Anderson E., Truelove S. C.. 1981. Disposition in normal volunteers of sodium azodisalicylate, a potential therapeutic agent in inflammatory bowl disease. Gut. 22: A431
   Web of Science ®Google Scholar
• Willoughby C. P., Aronson J. K., Agback H., Bodin N. O., Anderson E., Truelove S. C.. 1982. Disposition in normal volunteers of sodium azodisalicylate, a potential therapeutic agent in ulcerative colitis. Gut. 23: 1081–1087. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wong D., Larrabeo S., Clitford K., Tremblay J., Friend D. R.. 1997. USP dissolution apparatus III (reciprocating cylinder) for screening of guar-based colonic delivery formulation. J. Control. Rel.. 47: 173–179. [CROSSREF]
   Web of Science ®Google Scholar
• Yano H., Hirayama F., Kamada M., Arima H., Uekama K., Uekama K.. 2002. Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration. J. Control. Rel.. 79: 103–112. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yehe P. Y., Berenson M. M., Samowitz W. S., Kopeckova P., Kopecek J.. 1995. Site-specific drug delivery and penetration enhancement in the gastrointestinal tract. J. Control. Rel.. 36: 109–124. [CROSSREF]
   Web of Science ®Google Scholar
• Zhang H., Ibrahim A. A., Neau S. H.. 2002. An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int. J. Pharm.. 239: 197–205. [CROSSREF], [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar